Arcus Biosciences Appoints Global Immuno-Oncology Commercial Leader, Eric Hoefer as Chief Commercial Officer Portfolio News / By admin June 24, 2019
RAPT Therapeutics (Formerly FLX Bio) Completes $37 Million Series C Extension Portfolio News / By admin June 18, 2019
Dr. JJ Kang Promoted from Principal to Partner TCG News / By admin The Column Group announces the promotion of Dr. JJ Kang from Principal to Partner. Dr. Kang has been with TCG since 2015.
Exonics Therapeutics Acquired by Vertex, Expanding into New Disease Areas and Enhances Gene Editing Capabilities Portfolio News / By admin June 6, 2019
Constellation’s Interim Data for CPI-0610 in MANIFEST Clinical Trial Showed Signals of Clinical Activity in Myelofibrosis Patients Portfolio News / By admin June 3, 2019